Tuckson Reed Vaughn

Tuckson Reed Vaughn is listed in filings as Director at HENRY SCHEIN Inc. This profile follows SEC Form 4 activity through Mar 9, 2026, including 11 public disclosures. Recent filings connect the profile to HENRY SCHEIN Inc (HSIC) and Adverum Biotechnologies, Inc. (ADVM). The current snapshot covers public activity from Jun 20, 2024 to Mar 9, 2026. Reported amounts are shown as $578.3K to $62.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.